Sebastian Gaede, smartpatient CEO and founder

Mo­bile app de­vel­op­er adds dis­ease-spe­cif­ic mod­ules for pa­tients – and phar­ma part­ners

While phar­ma com­pa­nies have strug­gled to gain trac­tion with mo­bile apps for pa­tients, one de­vel­op­er is work­ing on a way to help. Smart­pa­tient is launch­ing dis­ease-spe­cif­ic mod­ules for its MyTher­a­py app — with phar­ma part­ner­ships.

The first add-on, MyTher­a­py MS, de­buted last week with 1,000 mul­ti­ple scle­ro­sis pa­tients al­ready us­ing it through a tri­al in Ger­many. Smart­pa­tient plans to ex­pand the MS mod­ule to Eu­rope and the US lat­er while al­so lin­ing up more dis­ease-spe­cif­ic mod­ules for asth­ma, pso­ri­a­sis, rheuma­toid arthri­tis and HIV for de­but over the next few months.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.